CAAS Qardia leverages AI-driven workflows to automate critical clinical measurements. Credit: Pie Medical Imaging / PRNewswire.

Cardiac imaging solutions provider Pie Medical Imaging has obtained NINSHO Medical Device Certification for its echocardiography software platform, CAAS Qardia, in Japan.

The certification enables the company to offer its CAAS Qardia solution to Japanese healthcare companies for off-cart viewing, analysis and reporting.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The platform is designed to provide efficient performance in analysing myocardial strain, evaluating diastolic function assessment, conducting stress-echo tests and performing PISA valve analysis.

It simplifies medical procedures by utilising artificial intelligence (AI)-driven workflows to automate critical clinical measurements and improve accessibility.

The emergence of automated calculation of myocardial strain, particularly its key clinical parameter global longitudinal strain (GLS), facilitates better assessment of cardiac function.

See Also:

Pie Medical Imaging managing director René Guillaume said: “With this certification of CAAS Qardia, an easy-to-use and accurate tool becomes available for Japanese healthcare institutions.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Rotterdam’s Cardialysis Core Laboratory chief medical officer Dr Ernest Spitzer is the first author of the CAAS Qardia myocardial strain validation paper.

It was found that it is possible to measure endocardial GLS using CAAS Qardia and that the obtained results are comparable to those obtained using commercial desktop software.

The study also concluded that the reproducibility of both using CAAS Qardia is similar to that of commercial desktop software.

In a statement, Spitzer said: “Beyond the implementation of a standardised method, the use of automation may soon expedite the increased use of quantitative parameters in clinical routine.”